U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07506161) titled 'Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas' on March 13.
Brief Summary: Researchers in this study aim to prove the safety and efficacy of radiofrequency ablation in the treatment of a carefully selected low-risk papillary thyroid microcarcinoma patient group.
Study Start Date: Sept. 09, 2021
Study Type: OBSERVATIONAL
Condition:
Papillary Thyroid Microcarcinoma
Intervention:
PROCEDURE: Radiofrequency ablation alone
Ultrasound-guided percutaneous radiofrequency ablation of T1N0M0 papillary thyroid microcarcinomas
Recruitment Status: COMPLETED
Sponsor: Premier G Med Cardio Kft
Information provi...